In vitro study demonstrates potent broad-spectrum antimicrobial activity of a novel cellulose nanocomposite, highlighting its potential for biological applications.
The present study developed a novel antimicrobial composite based on 2,3-dialdehyde cellulose (DAC), with biocompatible properties and long-term stability. Initially, DAC was synthesized through the periodate oxidation of microcrystalline cellulose, achieving a 61% degree of oxidation. Subsequently, the DAC was successfully modified through the formation of a Schiff base with CTI in the basic medium. The antimicrobial efficacy of the synthesized DAC-CTI was strengthened by the synthesis of Au NPs via a green chemical approach using lemon extract and their subsequent grafting into the DAC-CTI matrix, followed by encapsulation of the produced DAC-CTI/Au nanocomposite into the γ-cyclodextrin ring. The TEM results of DAC-CTI/Au nanocomposite indicated an average Au particle size of 37.4 nm within the nanocomposite. The evaluated samples reveal a positive efficacy against a variety of bacteria, including P. aeruginosa, C. albicans, and S. aureus. Particularly, DAC-CTI/Au NPs/γ-CD exhibited the highest effect on S. aureus (19.0 mm zone of inhibition (ZOI) and 2.5 µg/mL MIC), E. coli (20.0 mm ZOI and 1.25 µg/mL MIC), and C. albicans (18.2 mm ZOI and 2.5 µg/mL MIC). The outcomes achieved open the door to the practical implementation of intriguing compounds in biological fields.
No takes yet. Share an insight, caveat, or question.
Mahdy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: